Blog Listing

Seres Therapeutics is hiding a volatile catalyst.

In This Article:

  • Seres Therapeutics has a Phase I readout in ulcerative colitis (UC) coming.
  • The options chain implied volatility (IV) doesn’t seem to indicate importance.
  • Here we’ll discuss why this absolutely matters.
  • How we are playing this.

 

Read full article here.



Leave a Reply